- Home
- ESPR vs NBH Comparison
ESPR vs NBH Comparison
Compare ESPR & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- NBH
- Stock Information
- Founded
- ESPR 2008
- NBH 2002
- Country
- ESPR United States
- NBH United States
- Employees
- ESPR N/A
- NBH N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- ESPR Health Care
- NBH Finance
- Exchange
- ESPR Nasdaq
- NBH Nasdaq
- Market Cap
- ESPR 305.0M
- NBH 317.5M
- IPO Year
- ESPR 2013
- NBH N/A
- Fundamental
- Price
- ESPR $1.58
- NBH $10.39
- Analyst Decision
- ESPR Buy
- NBH
- Analyst Count
- ESPR 7
- NBH 0
- Target Price
- ESPR $6.36
- NBH N/A
- AVG Volume (30 Days)
- ESPR 4.2M
- NBH 85.9K
- Earning Date
- ESPR 03-04-2025
- NBH 01-01-0001
- Dividend Yield
- ESPR N/A
- NBH 4.34%
- EPS Growth
- ESPR N/A
- NBH N/A
- EPS
- ESPR N/A
- NBH 0.12
- Revenue
- ESPR $332,314,000.00
- NBH N/A
- Revenue This Year
- ESPR $5.51
- NBH N/A
- Revenue Next Year
- ESPR $1.42
- NBH N/A
- P/E Ratio
- ESPR N/A
- NBH $87.04
- Revenue Growth
- ESPR 185.66
- NBH N/A
- 52 Week Low
- ESPR $1.47
- NBH $8.75
- 52 Week High
- ESPR $3.94
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- ESPR 41.48
- NBH 35.18
- Support Level
- ESPR $1.47
- NBH $10.62
- Resistance Level
- ESPR $1.61
- NBH $10.50
- Average True Range (ATR)
- ESPR 0.12
- NBH 0.09
- MACD
- ESPR 0.00
- NBH -0.04
- Stochastic Oscillator
- ESPR 28.21
- NBH 16.35
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.